Skip to main content
SpringerLink
Log in

What is the relevance of resistance of Helicobacter pylori to antimicrobial agents?

  • Chapter
Helicobacter pylori

Abstract

The need to treat a Helicobacter pylori infection when associated with diseases such as peptic ulcer is now universally recognized.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Davis DB. Chemotherapy. In: Davis DB, Dulbecco R, Eisen HN et al., editors. Microbiology, 4th edn. Philadelphia: Lippincott; 1990:201–8.

    Google Scholar 

  2. Veldhuyzen Van Zanten SJ, Goldie J, Holligsworth J et al. Secretion of intravenously administered antibiotics in gastric juice: implication for management of Helicobacter pylori. J Clin Pathol. 1992;45:225–7.

    Article  Google Scholar 

  3. Harrison JD, Jones JA, Morris DC. Azithromycin levels in plasma and gastric tissue, juice and mucus. Eur J Clin Microbiol Infect Dis. 1991;10:862–4.

    Article  PubMed  CAS  Google Scholar 

  4. Darmaillac V, Bouchard S, Lamouliatte H, Mégraud F. Macrolides and Helicobacter pylori — determination of MICs and effect of pH. Gastroenterology. 1995;108:A78.

    Google Scholar 

  5. Mégraud F, Malfertheiner P. Treatment of Helicobacter pylori infection: summary of a meeting at the fourth United European Gastroenterology Week. Helicobacter. 1996; 1:118–21.

    Article  PubMed  Google Scholar 

  6. Labenz J, Gyenes E, Rühl GH, Borsch G. Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol. 1993;88:491–5.

    PubMed  CAS  Google Scholar 

  7. Butzler JP, Mégraud F. Campylobacter and Helicobacter pylori. In: Zinner S, Young L, Acar J, editors. New macrolides, azalides and streptogramins in clinical practice. New York: Marcel Dekker; 1996 (In press).

    Google Scholar 

  8. Occhialini A, Urdaci M, Doucet-Populaire F, Lamouliatte H, Bébéar CM, Mégraud F. Helicobacter pylori resistance to macrolides — confirmation of point mutation and detection by PCR-RFLP. Gut. 1996 (In press).

    Google Scholar 

  9. Versalovic J, Shortridge D, Kibler K et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother. 1996;40:477–80.

    PubMed  CAS  Google Scholar 

  10. Xia HX, Buckley M, Keane CT, O’Morain CA. Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro. J Antimicrob Chemother. 1996; 37:473–81.

    Article  PubMed  CAS  Google Scholar 

  11. Mégraud F, Camou-Juncas C, Occhialini A, Birac C. Helicobacter pylori resistance levels to clarithromycin remain stable. Gastroenterology. 1996; 100: A192.

    Google Scholar 

  12. Camou C, Ancelle J, Lamouliatte H, Mégraud F. Evolution of the resistance of Helicobacter pylori to macrolides. ICMAS 96, Lisbon.

    Google Scholar 

  13. Cayla R, Zerbib F, Talbi P, Mégraud F, Lamouliatte H. Pre and post treatment clarithromycin resistance of Helicobacter pylori strains: a key factor of treatment failure. Gut. 1995;37(Suppl. 1):A55.

    Google Scholar 

  14. Shültze K, Hentschel E, Hirschl AM. Clarithromycin or amoxicillin plus high dose ranitidine in the treatment of Helicobacter pylori positive functional dyspepsia. Eur J Gastroenterol Hepatol. 1996;8:41–6.

    Article  Google Scholar 

  15. Wurzer H, Rodrigo L, Archambault A et al. Short course therapy with amoxicillin-clarithroymcin triple for 10 days (ACT 10) eradicates H. pylori and heals duodenal ulcer. Gut. 1996 (In press).

    Google Scholar 

  16. Glupczynski Y, Labbé M, Hansen W et al. Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J Clin Microbiol. 1991;29:2072–5.

    PubMed  CAS  Google Scholar 

  17. Hirschl AM, Hirschl MM, Rotter ML. Comparison of three methods for the determination of the sensitivity of Helicobacter pylori to metronidazole. J Antimicrob Chemother. 1993;32:45.

    Article  PubMed  CAS  Google Scholar 

  18. Cederbrant G, Kahlmeter G, Ljungh A. Proposed mechanism for metronidazole resistance in Helicobacter pylori. J Antimicrob Chemother. 1992;29:115–20.

    Article  PubMed  CAS  Google Scholar 

  19. Van Zwet AA, Thijs JC, de Graaf B. Explanation for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains. Antimicrobiol Agents Chemother. 1995;39:250–2.

    Google Scholar 

  20. Smith MA, Edwards DI. Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter pylori to nitroheterocyclic drugs. J Antimicrobiol Chemother. 1995;35:751–64.

    Article  CAS  Google Scholar 

  21. Burette A, Glupczynski Y, Deprez C et al. Omeprazole alone or in combination with clarithromycin for eradication of Helicobacter pylori, results of a randomized double-blind controlled study. Gastroenterology. 1993;104:49.

    Google Scholar 

  22. Noach LA, Bosma NB, Tytgat GNJ. Clarithromycin resistance and Helicobacter pylori infection. European United Gastroenterology Week, Barcelona 1993;A103.

    Google Scholar 

  23. Lian JX, Carrick J, Daskalopoulos G. Metronidazole resistance significantly affects eradication of Helicobacter pylori infection. Gastroenterology. 1993; 104:133.

    Google Scholar 

  24. Logan RPH, Gummett PA, Misiewicz JJ et al. One week eradication regimen for Helicobacter pylori. Lancet. 1991;338:1249–52.

    Article  PubMed  CAS  Google Scholar 

  25. Bell GD, Powell K, Burridge SM et al. Experience with triple anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther. 1992;6:427–35.

    Article  PubMed  CAS  Google Scholar 

  26. Rautelin H, Kosunen TU, Seppala K. Eradicating Helicobacter pylori. Lancet. 1992;339:55.

    Article  PubMed  CAS  Google Scholar 

  27. Moayyedi P, Sahay P, Tompkins DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1-week triple regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol. 1996; 7:835–40.

    Google Scholar 

  28. Buckley M, Xia HX, Hyde D, O’Morain C. Cost effective, European approach to Helicobacter pylori eradication. Gut. 1995;37(Suppl. 2):A175.

    Google Scholar 

  29. Misiewicz JJ, Harris AW, Bardhan KD, Levis S, Langworthy H. One week low-dose triple therapy for eradication of H. pylori: a large multi centre randomised trial. Gastroenterology. 1996; 110: A198.

    Google Scholar 

Download references

Authors
  1. F. Mégraud
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Gastroenterology, McMaster University Medical Centre, 1200 Main Street West, Room 4W8, Hamilton, Ontario, L8N 3Z5, Canada

    Richard H. Hunt (Professor of Medicine, Director) (Professor of Medicine, Director)

  2. Department of Gastroenterology and Hepatology, Academic Medical Centre, 9 Meibergdreef, 1105 AZ, Amsterdam, The Netherlands

    Guido N. J. Tytgat (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Kluwer Academic Publishers and Axcan Pharma

About this chapter

Cite this chapter

Mégraud, F. (1996). What is the relevance of resistance of Helicobacter pylori to antimicrobial agents?. In: Hunt, R.H., Tytgat, G.N.J. (eds) Helicobacter pylori. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1792-7_35

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-1792-7_35

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7299-1

  • Online ISBN: 978-94-009-1792-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation